Reproductive tract immune cells from pregnant women or those using depot medroxyprogesterone acetate show no excess susceptibility to HIV-1: results of an ex vivo fusion assay

INTRODUCTION: Ex vivo fusion assays offer an efficient method for studying HIV-1 entry associated with contraceptive use and pregnancy outside of cohort studies of HIV-1 incidence. METHODS: We measured ex vivo HIV-1 fusion to cervical or endometrial immune cells from 3 groups of women: pregnant, non...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Contraception
Päätekijät: Seidman, Dominika, Cavrois, Marielle, Hilton, Joan F., Roan, Nadia R., Averbach, Sarah, Takeda, Margaret, Chang, Eric, Raman, Nandhini, Greenblatt, Ruth, Shacklett, Barbara L., Smith-McCune, Karen
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2020
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7736211/
https://ncbi.nlm.nih.gov/pubmed/33007299
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.contraception.2020.09.003
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia